Prolactin: How to Interpret Your Result

What Prolactin Actually Does

Prolactin is a 199-amino-acid polypeptide hormone secreted by lactotroph cells in the anterior pituitary gland. While its name reflects its role in milk production, this hormone participates in over 300 biological activities across reproductive, metabolic, and immune pathways [1].

Beyond Lactation

In women, prolactin prepares breast tissue during pregnancy and sustains milk synthesis postpartum. In men, prolactin contributes to reproductive function by modulating Leydig cell sensitivity to luteinizing hormone (LH). Chronically elevated prolactin suppresses gonadotropin-releasing hormone (GnRH) pulsatility from the hypothalamus, which reduces LH and follicle-stimulating hormone (FSH) secretion [2]. This suppression explains why hyperprolactinemia causes menstrual irregularity in women and low testosterone in men.

Dopamine as the Master Brake

Unlike most pituitary hormones, prolactin secretion is tonically inhibited rather than stimulated. Dopamine released from tuberoinfundibular neurons acts on D2 receptors on lactotroph cells to keep prolactin in check [3]. Any process that interrupts this dopamine signal (pituitary stalk compression, dopamine-blocking medications, hypothalamic lesions) can raise prolactin.

Prolactin also follows a circadian rhythm: levels peak during sleep, with the highest concentrations occurring 2 to 5 hours after sleep onset. A single random blood draw captures only one point on that curve, which is why standardized morning fasting samples produce the most reliable results [4].

Normal Prolactin Ranges and How to Read Yours

Reference ranges differ across laboratories, assay platforms, and patient populations. A result cannot be interpreted without knowing the specific lab's cutoff. Most accredited labs converge on similar thresholds.

Standard Reference Intervals

For non-pregnant, non-lactating adults, serum prolactin typically falls between 2 and 18 ng/mL (or 2 to 18 µg/L, since 1 ng/mL = 1 µg/L). The Endocrine Society's 2011 clinical practice guideline defines hyperprolactinemia as a sustained serum prolactin above the upper limit of normal, generally above 25 ng/mL, confirmed on at least two separate measurements [5]. Men tend to have slightly lower median values than premenopausal women.

Pregnancy and Postpartum Shifts

During pregnancy, estrogen-driven lactotroph hyperplasia can raise prolactin tenfold. Third-trimester levels of 200 to 500 ng/mL are physiologically normal and should not trigger an adenoma workup [6]. Postpartum, prolactin remains elevated in breastfeeding women and can take 6 to 12 months to normalize after weaning.

When Mild Elevation Isn't Pathologic

Stress, nipple stimulation, vigorous exercise, a high-protein meal, or even the venipuncture itself can transiently raise prolactin by 10 to 20 ng/mL. The Endocrine Society recommends repeating any borderline result (25 to 40 ng/mL) on a separate day, drawn fasting, at rest, and without preceding breast examination [5]. A single mildly elevated value in isolation does not confirm hyperprolactinemia.

Causes of High Prolactin (Hyperprolactinemia)

Elevated prolactin is one of the most common pituitary abnormalities encountered in endocrine practice, affecting up to 0.4% of the general population and roughly 9 to 17% of women with reproductive disorders [7].

Medication-Induced Elevation

The most frequent cause of hyperprolactinemia is pharmacologic dopamine blockade. Typical antipsychotics (haloperidol, chlorpromazine) raise prolactin in 40 to 90% of patients, often to levels of 25 to 100 ng/mL. Atypical antipsychotics vary: risperidone and paliperidone are strong prolactin elevators, while aripiprazole, a partial D2 agonist, may actually lower prolactin [8]. Metoclopramide, domperidone, and certain SSRIs also raise prolactin through D2 antagonism or serotonergic mechanisms [5].

Before launching an expensive imaging workup, a thorough medication reconciliation is the single most important step. The Endocrine Society guideline recommends discontinuing or substituting the suspected drug (when safe) and rechecking prolactin after 72 hours, or after 3 days of drug washout if clinically feasible [5].

Prolactinomas

Prolactin-secreting pituitary adenomas (prolactinomas) account for roughly 40% of all pituitary tumors. Microprolactinomas (<10 mm) typically produce prolactin levels of 50 to 200 ng/mL. Macroprolactinomas (≥10 mm) usually push levels above 200 ng/mL, and values exceeding 250 ng/mL carry high positive predictive value for a macroprolactinoma [9]. A general rule: the degree of prolactin elevation correlates with tumor size.

The Hook Effect: A Diagnostic Trap

In very large tumors secreting extremely high prolactin (often >10,000 ng/mL), the immunoassay can become saturated and report a falsely normal or only mildly elevated result. This is the "hook effect." Clinicians should request serial dilution (1:100) of any sample from a patient with a large sellar mass and a prolactin result that seems disproportionately low [10]. Missing this artifact can lead to unnecessary surgery on what is actually a medically treatable prolactinoma.

Other Pathologic Causes

Hypothyroidism raises prolactin through elevated thyrotropin-releasing hormone (TRH), which co-stimulates lactotroph cells. Checking TSH is part of any hyperprolactinemia workup [5]. Chronic kidney disease reduces prolactin clearance, with levels above 30 ng/mL found in up to 30% of patients on dialysis [11]. Chest wall irritation (herpes zoster, post-surgical scarring) can also raise prolactin via afferent neural pathways to the hypothalamus.

Causes of Low Prolactin (Hypoprolactinemia)

Low prolactin receives far less clinical attention than elevated levels, but values consistently below the lower limit of normal may carry significance.

Pituitary Insufficiency

A prolactin below 2 ng/mL, especially in the context of other low pituitary hormones (low TSH, low ACTH, low gonadotropins), may signal hypopituitarism from pituitary infarction (Sheehan syndrome), surgery, radiation, or infiltrative disease [12]. In postpartum women, inability to lactate combined with undetectable prolactin should prompt evaluation for Sheehan syndrome, which occurs in an estimated 5 per 100,000 deliveries worldwide [13].

Dopamine Agonist Overshoot

Patients on cabergoline or bromocriptine for prolactinoma treatment sometimes overshoot the target. Prolactin values suppressed well below the normal range for prolonged periods have been associated with metabolic changes in some observational studies, though definitive harm thresholds are not established [14].

Clinical Relevance of Low Values

Emerging evidence links low prolactin to increased metabolic syndrome prevalence and reduced immune surveillance, though these associations remain correlational. A 2020 cross-sectional study of 3,055 adults found that men in the lowest prolactin quartile had significantly higher rates of metabolic syndrome components compared to those in the second and third quartiles [15]. This is an active area of research, and clinical guidelines do not yet recommend treating isolated mild hypoprolactinemia.

How the Prolactin Test Is Performed

Sample Collection

A standard serum prolactin test requires a simple venous blood draw. The Endocrine Society recommends a fasting morning sample, ideally collected 2 to 3 hours after waking and at least 1 hour after any breast stimulation or vigorous activity [5]. Stress from the venipuncture itself can raise prolactin; some clinicians insert a heparin lock, wait 15 to 20 minutes, then draw the sample to avoid this artifact.

Macroprolactin Screening

Approximately 10 to 25% of patients with elevated serum prolactin have macroprolactinemia, a condition where prolactin circulates bound to IgG antibodies as a high-molecular-weight complex ("big-big prolactin") [16]. Macroprolactin is biologically inactive but detected by most immunoassays, leading to falsely elevated results. Polyethylene glycol (PEG) precipitation is the standard screening method: if more than 60% of total prolactin precipitates with PEG, macroprolactinemia is likely. Many labs now automatically perform PEG precipitation on elevated samples, but not all do. Always check whether your lab reports monomeric (bioactive) prolactin or total prolactin.

Interpreting Results in Context

A single prolactin number means little without clinical context. The diagnostic framework involves four questions:

1. Is the patient on a dopamine-blocking medication? If yes, attribute the elevation to the drug before imaging.
2. Is TSH elevated? Primary hypothyroidism causes secondary hyperprolactinemia that resolves with levothyroxine.
3. Does the level match the imaging finding? A macroadenoma with prolactin of only 45 ng/mL suggests stalk effect (compression of the pituitary stalk blocking dopamine delivery), not a prolactinoma. A true macroprolactinoma would typically produce levels above 200 ng/mL [5].
4. Was macroprolactin excluded? If PEG precipitation was not performed, request it before proceeding.

How to Lower Prolactin

Dopamine Agonist Therapy

Cabergoline is the first-line pharmacologic treatment for symptomatic hyperprolactinemia from any cause. In a randomized trial of 459 women with hyperprolactinemic amenorrhea, cabergoline normalized prolactin in 83% of patients compared to 59% with bromocriptine, with significantly fewer side effects [17]. The standard starting dose is 0.25 mg twice weekly, titrated every 4 weeks based on serum prolactin response. The Endocrine Society recommends monitoring prolactin levels at 1 month, then every 3 to 6 months during dose adjustment [5].

Addressing Underlying Causes

For medication-induced hyperprolactinemia, switching from risperidone to aripiprazole can lower prolactin by 70 to 80% within 8 weeks, based on data from a meta-analysis of 639 patients [8]. For hypothyroidism-driven elevations, correcting TSH with levothyroxine normalizes prolactin within weeks. No pharmacologic intervention is needed in these scenarios beyond treating the root cause.

Lifestyle Factors

Chronic psychological stress increases prolactin through hypothalamic-pituitary activation. While no randomized trials have tested stress reduction as a prolactin-lowering intervention specifically, normalization of the hypothalamic-pituitary-adrenal axis is a recognized component of managing functional hyperprolactinemia [18]. Vitamin B6 (pyridoxine) has been proposed as a mild prolactin modulator, but clinical evidence is limited to small, low-quality studies, and no guideline endorses supplementation for this purpose.

How Prolactin Affects Fertility and Hormones

The GnRH Suppression Pathway

Hyperprolactinemia is a well-established cause of secondary hypogonadism in both sexes. Elevated prolactin suppresses hypothalamic GnRH pulse frequency, leading to decreased LH and FSH secretion. In women, this manifests as oligomenorrhea, amenorrhea, or anovulatory cycles. In men, it presents as low testosterone, reduced libido, and erectile dysfunction [2].

Fertility Restoration

Normalizing prolactin with cabergoline restores ovulation in approximately 80 to 90% of women with prolactinoma-associated amenorrhea [17]. In men with prolactinoma-induced hypogonadism, dopamine agonist therapy typically restores testosterone to eugonadal levels within 3 to 6 months, though semen parameters may take 12 to 18 months to fully recover [19]. Testosterone replacement alone (without addressing the elevated prolactin) is not recommended because it does not restore fertility and may mask the underlying pituitary pathology.

Bone Density Considerations

Prolonged hyperprolactinemia-induced hypogonadism leads to accelerated bone loss. A study of 47 men with prolactinomas found that lumbar spine bone mineral density was significantly reduced compared to age-matched controls, with partial recovery after 2 years of cabergoline therapy [20]. The Endocrine Society recommends bone density assessment (DXA scan) in any patient with hyperprolactinemia lasting more than 12 months in the setting of hypogonadism [5].

When to Retest and Follow Up

After Starting Treatment

For patients starting cabergoline, prolactin should be rechecked at 4 weeks, then every 3 to 6 months until stable. Once prolactin is normalized and the dose is stable for 2 or more years, guidelines suggest considering a trial taper or discontinuation, particularly for microprolactinomas [5]. Roughly 30 to 40% of patients with microprolactinomas can successfully stop cabergoline without recurrence after 2 years of normoprolactinemia [21].

MRI Timing

For newly diagnosed macroprolactinomas, a follow-up pituitary MRI is recommended 3 to 6 months after starting dopamine agonist therapy. Tumor shrinkage of 25 to 50% within the first 3 months is typical and confirms the diagnosis. Microprolactinomas generally do not require routine MRI surveillance if prolactin remains normal on treatment.

Cardiac Valve Monitoring

High cumulative doses of cabergoline (as used in Parkinson disease at 3+ mg/day) have been linked to cardiac valve fibrosis. At the lower doses used for prolactinomas (typically 0.5 to 2 mg/week), the risk appears minimal. A meta-analysis of 8 studies involving 578 patients on standard-dose cabergoline found no significant increase in clinically relevant valvulopathy [22]. The Endocrine Society states that routine echocardiographic monitoring is not required at doses below 2 mg/week but should be considered at higher doses or with prolonged use exceeding 5 years.